Drug
Iobitridol
Iobitridol: highest development phase Post-Market, developed by Guerbet. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Guerbet
Trials
| Drug | Phase | Indication |
|---|---|---|
| Iobitridol NCT00382317 | Post-Market | Diagnostic Imaging |
| iobitridol NCT01255722 | Post-Market | Coronary Artery Disease |
| iobitridol NCT01254552 | Post-Market | Type 2 Diabetes Mellitus |
Latest
No recent events.
Follow Iobitridol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.